Evidence map›Paper›PMID 24966947›Full record

ArticleInternational journal of clinical and experimental pathology2014

EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.

Chien-Hung Lin, Li-Keng Chao, Peir-Haur Hung, Yann-Jang Chen

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chien-Hung LinInstitute of Clinical Medicine, National Yang-Ming University Taipei, Taiwan ; Department of Pediatrics, Zhongxing Branch, Taipei City Hospital Taipei, Taiwan.
Li-Keng ChaoInstitute of Tranditional Medicine, National Yang-Ming University Taipei, Taiwan ; Department of Internal Medicine, Tzu Chi Medical Center Hualien, Taiwan.
Peir-Haur HungDepartment of Medical Research, Ditmanson Medical Foundation Chia-yi Christian Hospital Chia-yi, Taiwan.
Yann-Jang ChenInstitute of Clinical Medicine, National Yang-Ming University Taipei, Taiwan ; Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University Taipei, Taiwan ; Department of Pediatrics, Renai Branch, Taipei City Hospital Taipei, Taiwan.
National Yang Ming Chiao Tung University · TWChia-Yi Christian Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A subset of cancer cells, termed cancer stem cells (CSCs) or tumor-initiating cells (TICs) could initiate tumors and are responsible for tumor recurrence and chemotherapeutic resistance. In this study, we enriched TICs in nasopharyngeal carcinoma (NPC) by the spheres formation and characterized the stem-like signatures such as self-renewal, proliferation, chemoresistance and tumorigenicity. By this method, we investigated that epigallocathechin gallate (EGCG), the major polyphenol in green tea could target TICs and potently inhibit sphere formation, eliminate the stem-like properties and enhance chemosensitivity in NPC through attenuation of STAT3 activation, which could be important in regulating the stemness expression in NPC. Our results demonstrated that STAT3 pathway plays an important role in mediating tumor-initiating capacities in NPC and suggest that inactivation of STAT3 with EGCG may represent a potential preventive and therapeutic approach for NPC.

Indexed as

Antineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsCarcinomaCatechinCell Line, TumorCell ProliferationCell SurvivalCisplatinDose-Response Relationship, DrugGene Expression Regulation, NeoplasticHumansNasopharyngeal CarcinomaNasopharyngeal NeoplasmsNeoplastic Stem CellsSignal TransductionSpheroids, CellularAntineoplastic Agents, PhytogenicCatechinCisplatinepigallocatechin gallateSTAT3 protein, humanSTAT3 Transcription FactorEGCGnasopharyngeal cancerSTAT3

Identifiers

PMID24966947
PMCPMC4069954
OpenAlexW1424089594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.